Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Ind-Swift Ltd.

NSE: INDSWFTLTD | BSE:524652

₹21.15 -0.05 (-0.24%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

20.90

Today’s High

21.80

52W low

11.80

52W High

31.20

Open Price

21.30

Prev. Close

20.5000

Volume

33844.00

Value

715800.60

Fundamentals

Market Cap Cr

114.60

Price to Earnings

8.00

Price to Book Value

-0.20

Dividend Yield

0.00

PE to Growth

-0.20

Op Revenue TTM Cr

502.25

Net Profit TTM Cr

14.23

Cash From Operating Activity Cr

15.28

Return on Equity %

-2.06

EMA & SMA

Bullish Moving Averages

5

Bearish Moving Averages

11

5Day EMA

21.4

10Day EMA

21.4

12Day EMA

21.4

20Day EMA

21.5

26Day EMA

21.5

50Day EMA

21.4

100Day EMA

20.8

200Day EMA

19

5Day SMA

21.4

10Day SMA

21.4

20Day SMA

21.3

30Day SMA

21.4

50Day SMA

22

100Day SMA

20.8

150Day SMA

19.8

200Day SMA

19.2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

100

Week

100

Month

100

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

21.17

PIVOT

First Resistance

21.83

Second Resistance

22.47

Third Resistance

23.13

First Support

20.53

Second Support

19.87

Third Support

19.23

Relative Strength Index

46.53

Money Flow Index

55.38

MACD

-0.06

MACD Signal

-0.07

Average True Range

1.19

Average Directional Index

16.34

Rate of Change (21)

0.95

Rate of Change (125)

17.78

Commodity Channel Index

-16.2

Williams %R

-68.2

BETA

1 Month

0.57

3 Month

0.81

1 Year

0.68

3 Year

0.08

PRICE CHANGE ANALYSIS

↓ -0.94%

1 Week

Low

High

20.5

22.58

↑ 0.71%

1 Month

Low

High

18.95

22.7

↑ 8.74%

3 Months

Low

High

18.95

31.2

↑ 16.85%

6 Months

Low

High

14.3

31.2

↑ 65.23%

1 Year

Low

High

11.8

31.2

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 181.82 105.18 119.07 154.17 112.16 109.79 104.82 96.18 112.64 107.16 103.00
Operating Expenses Qtr 120.75 98.07 104.78 130.14 97.92 88.69 92.90 89.55 95.59 92.32 84.69
Operating Profit Qtr 14.49 4.49 11.14 18.40 7.95 17.89 10.92 5.13 9.98 12.03 12.69
EBIDT Qtr Cr 61.08 7.11 14.29 24.03 74.81 21.10 11.93 6.63 17.06 15.58 18.31
Depreciation Qtr 6.88 6.78 6.73 6.72 7.24 7.29 7.13 7.01 8.30 7.99 7.95
Net Profit Qtr 37.54 -14.97 -10.71 2.36 53.10 -1.03 -10.59 -15.44 -5.48 -6.04 -4.93
Basic EPS Qtr 6.93 -2.76 -1.98 0.44 9.80 -0.19 -1.96 -2.85 -1.01 -1.11 -0.91
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 560.24 422.81 421.26 365.33 345.40
Operating Expenses Annual Cr 453.73 368.93 352.36 314.68 306.18
Operating Profit Annual 48.51 42.03 45.35 41.37 23.34
Operating Profit Margin Annual % 8.66 9.94 10.77 11.33 6.76
Total Expenses Annual Cr 543.78 457.35 441.60 393.62 368.46
EBIDT Annual Cr 106.51 53.89 68.90 50.65 39.22
EBIDT Annual margin % 19.01 12.74 16.35 13.86 11.35
Depreciation 27.11 28.67 32.07 32.70 33.59
PAT Before ExtraOrdinary Items Annual Cr 14.23 26.04 -20.02 -29.82 -19.12
Net Profit Annual 14.23 26.04 -20.02 -29.82 -19.12
Basic EPS Annual 2.63 4.81 -3.70 -5.50 -6.71
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual -690.83 -690.50 -706.12 -680.96 -698.92
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 1024.93 403.38 620.29 646.38 646.44
Total Current Liabilities Annual Cr 320.37 936.33 717.59 706.16 654.13
Total Capital Plus Liabilities Annual Cr 654.47 649.21 631.76 671.57 601.65
Fixed Assets Annual 235.29 246.19 244.51 257.07 269.66
Total Non Current Assets Annual 312.68 375.83 389.31 406.40 373.00
Total Current Assets Annual 341.79 273.38 242.44 265.17 228.65
Total Assets Annual 654.47 649.21 631.76 671.57 601.65
Contingent Liabilities plus Commitments Annual Cr - 0.38 5.56 1.82 1.03
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 15.28 73.05 89.63 77.24 34.60
Cash from Investing Activity Annual 76.61 -29.34 -18.42 -16.71 -11.35
Cash from Financing Annual Activity -42.08 -46.56 -84.02 -48.30 -26.20
Net Cash Flow Annual - -2.85 -12.81 12.23 -2.96
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual -127.54 -130.10 -132.99 -128.34 -131.66
ROE Annual % -2.06 -3.69 0.00 0.00 0.00
ROCE Annual % 23.76 -8.78 -42.90 -51.87 -10.71
Total Debt to Total Equity Annual -1.47 -1.39 -1.42 -1.45 -1.40
EBDIT Annual Margin % 21.20 13.11 17.32 14.22 11.90
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Graph
Total Qtr Revenue cr 181.82 105.18 119.07 154.17 112.16 109.79 104.82 96.18 112.64
Operating Expenses Qtr 120.75 98.07 104.78 130.14 97.92 88.69 92.90 89.55 95.59
Operating Profit Qtr 14.49 4.49 11.14 18.40 7.95 17.89 10.92 5.13 9.98
EBIDT Qtr Cr 61.08 7.11 14.29 24.03 74.81 21.10 11.93 6.63 17.06
Depreciation Qtr 6.88 6.78 6.73 6.72 7.24 7.29 7.13 7.01 8.30
Net Profit Qtr 37.54 -14.97 -10.71 2.36 53.10 -1.03 -10.59 -15.44 -5.48
Basic EPS Qtr 6.93 -2.76 -1.98 0.44 9.80 -0.19 -1.96 -2.85 -1.01
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2018 Mar 2017 Graph
Total Revenue Annual 560.24 422.81 421.26 280.73 280.88
Operating Expenses Annual Cr 453.73 368.93 352.36 264.27 332.60
Operating Profit Annual 48.51 42.03 45.35 6.30 -65.40
Operating Profit Margin Annual % 8.66 9.94 10.77 2.24 -23.28
Total Expenses Annual Cr 543.78 457.35 441.60 305.96 384.65
EBIDT Annual Cr 106.51 53.89 68.90 16.46 -51.72
EBIDT Annual margin % 19.01 12.74 16.35 5.86 -18.41
Depreciation 27.11 28.67 32.07 34.63 35.73
PAT Before ExtraOrdinary Items Annual Cr 14.23 26.04 -20.02 -54.13 -364.27
Net Profit Annual 14.23 26.04 -20.02 -50.43 -372.71
Basic EPS Annual 2.63 4.81 -3.70 -9.36 -69.04
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2018 Mar 2017 Graph
Total ShareHolders Funds Annual -690.83 -704.70 -720.32 -663.18 -615.50
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 1024.93 417.58 634.05 679.69 672.22
Total Current Liabilities Annual Cr 320.37 936.33 718.03 598.24 607.85
Total Capital Plus Liabilities Annual Cr 654.47 649.21 631.76 614.75 664.56
Fixed Assets Annual 235.29 246.19 244.51 310.68 344.53
Total Non Current Assets Annual 312.68 375.83 389.31 428.64 458.13
Total Current Assets Annual 341.79 273.38 242.44 186.11 206.43
Total Assets Annual 654.47 649.21 631.76 614.75 664.56
Contingent Liabilities plus Commitments Annual Cr - 0.38 0.25 35.31 33.97
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2018 Mar 2017 Graph
Cash from Operating Activity Annual 15.28 73.05 50.20 7.17 -1.72
Cash from Investing Activity Annual 76.61 -29.34 -18.42 -6.42 4.14
Cash from Financing Annual Activity -42.08 -46.56 -44.59 -6.17 -10.71
Net Cash Flow Annual - -2.85 -12.81 -5.43 -8.28
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2018 Mar 2017 Graph
Book Value Per Share Annual -127.54 -130.10 -132.99 -125.06 -116.26
ROE Annual % -2.06 -3.69 0.00 0.00 0.00
ROCE Annual % 23.76 -8.78 -42.68 -110.04 -154.20
Total Debt to Total Equity Annual -1.47 -1.41 -1.44 -1.54 -1.66
EBDIT Annual Margin % 21.20 13.11 17.32 6.08 -19.35
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
S. R. MEHTA 3.76 75061679 29.83 0
GOPAL MUNJAL 3.61 75061680 32.99 0
V.R. MEHTA 3.55 75061681 25.65 0
SUNITA JAIN 3.35 75061682 100 0
NEERA MEHTA 2.86 75061683 100 0
RAVI MEHTA 1.17 75061684 100 0
N.R. MUNJAL 1.13 75061685 100 0
NEETA MUNJAL 1.07 75061686 100 0
NIDHI MUNJAL 0.93 75061687 100 0
HIMANSHU JAIN 0.91 75061688 100 0
MEENAKSHI MEHTA 0.74 75061689 100 0
ESSIX BIOSCIENCES LIMITED 31.45 75061700 23.48 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
SHARWAN SINGH GULERIA 1.9 75061714
RAMESHKUMAR JAVERCHAND JAIN 1.77 75061715
HUF 1.15 75061705
JUSTIN PHARMACEUTICALS PRIVATE LIMITED 1.59 75061708
GRAVITY SYSTEMS PRIVATE LIMITED 1.38 75061709
PANCHKULA FINVEST PRIVATE LIMITED 1.31 75061710
EXCEL MOTORS PRIVATE LIMITED 1.08 75061711
DEEPA RAM KHERIA 1.55 75061717
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 21, 2011 0.4 FINAL - Equity Share
Sep 24, 2010 0.4 FINAL - Equity Share
Sep 17, 2009 0.4 FINAL - Equity Share
Sep 19, 2008 0.4 FINAL - Equity Share
Sep 21, 2007 0.4 FINAL - Equity Share
Sep 28, 2006 0.4 FINAL - Equity Share
Sep 22, 2005 0.4 FINAL - Equity Share
Sep 23, 2004 2 FINAL - Equity Share
Oct 16, 2003 2 FINAL - Equity Share
Sep 11, 2002 - FINAL - Equity Share
Aug 27, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Apr 29, 2005 10:2 2005-05-06
Ex-Date Purpose Notes
May 14, 2024 Audited Results -
Feb 14, 2024 Quarterly Results (Revised)
Nov 09, 2023 Quarterly Results -
Aug 10, 2023 Quarterly Results -
May 30, 2023 Audited Results -
Feb 13, 2023 Quarterly Results -
Nov 14, 2022 Quarterly Results -
Aug 09, 2022 Quarterly Results -
May 30, 2022 Audited Results -
Feb 14, 2022 Quarterly Results -
Nov 13, 2021 Quarterly Results -
Aug 14, 2021 Quarterly Results -
Jun 28, 2021 Audited Results -
Feb 13, 2021 Quarterly Results -
Nov 11, 2020 Quarterly Results -
Aug 10, 2020 Quarterly Results -
Jun 27, 2020 Audited Results -
Feb 13, 2020 Quarterly Results -
Nov 14, 2019 Quarterly Results -
Aug 10, 2019 Quarterly Results -
May 30, 2019 Audited Results -
Feb 11, 2019 Quarterly Results -
Nov 14, 2018 Quarterly Results -
Aug 14, 2018 Unaudited Financial Results -
May 30, 2018 Audited Results -
Feb 13, 2018 Quarterly Results -
Dec 14, 2017 Quarterly Results -
Sep 14, 2017 Quarterly Results -
May 30, 2017 Audited Results -
Feb 13, 2017 Quarterly Results -
Nov 10, 2016 Quarterly Results -
Aug 10, 2016 Quarterly Results -
May 30, 2016 Audited Results Appointment of Ms. Simrat Kaur as Company Secretary & Compliance Officer of the Company.
Mar 12, 2016 Resignation of Company Secretary -
Feb 12, 2016 Quarterly Results -
Nov 07, 2015 Quarterly Results -
Aug 10, 2015 Quarterly Results -
May 04, 2015 Audited Results -
Feb 13, 2015 Quarterly Results -
Nov 07, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results & Others Issue of shares on preferential basis to promoters against their contribution in terms of CDR package as sanctioned by the Corporate Debt Restructuring cell.
Jun 04, 2014 Audited Results Adjourn board meeting from 28/05/2014.
Feb 10, 2014 Quarterly Results -
Nov 11, 2013 Quarterly Results -
Aug 09, 2013 Quarterly Results -
May 28, 2013 Audited Results -
Feb 12, 2013 Quarterly Results -
Nov 07, 2012 Quarterly Results -
Aug 28, 2012 Audited Results (15 months)
May 15, 2012 Quarterly Results -
Feb 08, 2012 Quarterly Results & Others The Board has allotted 40,00,000 Equity Shares (par value Rs. 2/- each) to the Promoter Group entities upon conversion of 40,00,000 ZCOCWs (2010 Series) at a price of Rs. 40/- per Share.
Nov 14, 2011 Quarterly Results -
Aug 31, 2011 Audited Results & Dividend -
Aug 10, 2011 Quarterly Results -
May 12, 2011 Quarterly Results -
Mar 25, 2011 Allotment of Equity Shares To consider the followings: 1. Allotment of Equity Shares upon conversion of Zero Coupon Convertible Warrants issued on preferential basis. 2. Allotment of Preference Shares.
Feb 11, 2011 To consider the allotment of ZCCWs Inter alia, to consider the allotment of 80,00,000 Zero Coupon Convertible Warrants on preferential basis, as approved by the Shareholders at the Annual General Meeting held September 30, 2010.
Jan 29, 2011 Quarterly Results -
Nov 13, 2010 Quarterly Results -
Sep 06, 2010 Audited Results, Dividend & Others The Board has considered the followings: 1. Preferential issue of 80,00,000 CW's to Promoters Group & other Corporate Bodies to be issued on preferential basis. 2. Issue of Preference Shares.(Revised)
Jul 28, 2010 Quarterly Results -
Apr 30, 2010 Quarterly Results & Others The Board has decided to convert 19,56,000 Zero Coupon Convertible Warrants, (out of 40,00,000 Warrants) allotted to Essix Biosciences Ltd. into Equal no. of Equity Shares of Rs. 2/- each.
Feb 22, 2010 Allotment of Zero Coupon CW's The BoD's has allotted 40,00,000 Zero Coupon CW's on preferential basis to M/s. Essix Bio-Sciences Ltd., at a rate of Rs. 25/- per Warrant (each Conv. into one Equity Share of Rs. 2/- each).
Jan 28, 2010 Quarterly Results -
Oct 30, 2009 Quarterly Results -
Oct 08, 2009 To approve the allotment of ZCCW's To consider and approve 40,00,000 Zero Coupon Convertible Warrants on preferential basis to M/s. Essix Bio-Sciences Ltd. as approved by the shareholders at the AGM of the Co. held on Sept 24, 2009.
Aug 31, 2009 Preferential Issue The Borad has considered the Preferential Issue of 40,00,000 Convertible Warrants to promoters group to be issued on preferential basis.
Jul 30, 2009 Quarterly Results -
Apr 29, 2009 Quarterly Results -
Jan 29, 2009 Quarterly Results -
Oct 25, 2008 Quarterly Results -
Aug 29, 2008 Allotment of equity shares To consider allotment of equity shares to promoters Group Company of Zero Coupon warrants into equity shares.
Aug 23, 2008 Audited Results, Dividend & Others To fix the date for Annual General Meeting.
Jul 30, 2008 Quarterly Results -
Apr 28, 2008 Quarterly Results -
Jan 30, 2008 Quarterly Results (Revised)
Oct 29, 2007 Quarterly Results -
Sep 03, 2007 Audited Results & Dividend -
Jul 30, 2007 Quarterly Results -
Apr 30, 2007 Quarterly Results -
Oct 28, 2006 Quarterly Results -
Aug 31, 2006 Accounts & Dividend -
Jul 29, 2006 Quarterly Results -
Apr 28, 2006 Quarterly Results -
Jan 30, 2006 Quarterly Results -
Oct 29, 2005 Quarterly Results -
Aug 20, 2005 Accounts & Dividend (Revised)
Jul 30, 2005 Quarterly Results -
Jul 20, 2005 Allotment of equity shares To consider and approve interalia, the allotment of equity shares of the Company upon conversion of Zero Coupon optionally convertible Warrants.
Apr 30, 2005 Quarterly Results -
Mar 31, 2005 To consider allotment of equity shares To consider allotment of equity shares of the company upon conversion of Zero Coupon Optionally Convertible Warrants.
Mar 23, 2005 Sub Division of Equity shares -
Jan 22, 2005 Quarterly Results -
Nov 30, 2004 Others To allot 8,50,000 warrants to promoters of the company and allotment of 6,50,000 warrants to bodies corporate convertible into equity shares at any time within 18 months.
Oct 16, 2004 Others To decide the issue of further shares/warrants convertible into shares/other convertible instrument, on preferential basis.
Aug 30, 2004 Accounts -
Jul 28, 2004 Quarterly Results & Others Allotment of shares to the shareholders of Mukur Pharmaceuticals Co. Pvt. Ltd., & Swift Formulations Pvt. Ltd., consequent upon amalgamation with the company.
Apr 30, 2004 Quarterly Results -
Mar 31, 2004 Others The Board will consider the conversion of 6,50,000 Zero coupon Warrants into Equity shares of the company.
Mar 04, 2004 Others 1) To consider the holding of an EGM for: a) Issuance of Global Depository Receipts. b) Extension of time for the conversion of some warrants into equity shares issued on Preferential Basis.
Jan 22, 2004 Quarterly Results To consider allotment of 3,50,000 Zero Coupons (Revised)
Oct 23, 2003 Quarterly Results -
Sep 27, 2003 ADR/GDR issue ADR/GDR issue & Preferential Issue of shares
Jul 31, 2003 Quarterly Results -
Apr 28, 2003 Quarterly Results (Revised)
Apr 22, 2003 Others Amalgamation of Mukur Pharmaceutical Co. Pvt. Ltd. and Swift Formulations Pvt. Ltd. with the Company.
Jan 21, 2003 Quarterly Results -
Jan 06, 2003 Accounts & Others To approve the draft scheme of amalgamation of Mukur Pharmaceutical Co. Pvt. Ltd., and Swift Formulations Pvt. Ltd., with the company.
Dec 18, 2002 Others Decision to consolidate the group affairs and activities, so as to emerge as a much stronger single business unit.
Oct 26, 2002 Quarterly Results -
Aug 14, 2002 Accounts & Dividend -
Jul 27, 2002 Quarterly Results -
Apr 30, 2002 Quarterly Results -
Jan 30, 2002 Quarterly Results -
Oct 30, 2001 Quarterly Results -
Aug 13, 2001 Accounts & Dividend -
Jul 28, 2001 Quarterly Results -
Apr 27, 2001 Quarterly Results -
Jan 20, 2001 Quarterly Results -
Oct 30, 2000 Quarterly Results -
Aug 10, 2000 Accounts -
Jul 31, 2000 Quarterly Results -
Jun 28, 2000 Accounts -
Jun 17, 2000 Preferential Offer -
Apr 26, 2000 Quarterly Results -
Feb 22, 2000 Preferential Offer -
Ex-Date Bonus Ratio Record Date
Bigul
29 Jun 2024

IND-SWIFT LTD. - 524652 - Closure of Trading Window

 Closure of trading window for quarter ended 30.06.2024
Bigul
27 Jun 2024

IND-SWIFT LTD. - 524652 - Announcement Under Regulation 30 Of SEBI LODR, 2015

 Announcement under Regulation 30
Bigul
17 Jun 2024

IND-SWIFT LTD. - 524652 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 Submission of Scrutinizer''s report
Bigul
17 Jun 2024

IND-SWIFT LTD. - 524652 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

 Outcome of Postal ballot
Bigul
30 May 2024

IND-SWIFT LTD. - 524652 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance report for period ended March 2024
Bigul
18 May 2024

IND-SWIFT LTD. - 524652 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 18, 2024

 Outcome of Board meeting dated May 18, 2024
Bigul
16 May 2024

IND-SWIFT LTD. - 524652 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Publication informing about postal ballot and e-voting information.
Bigul
16 May 2024

IND-SWIFT LTD. - 524652 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Publication of Audited financial results for the quarter and year ended 31.04.2024.
Bigul
15 May 2024

IND-SWIFT LTD. - 524652 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Notice of postal ballot
Bigul
14 May 2024

IND-SWIFT LTD. - 524652 - Financial Results For Quarter And Year Ended 31.03.2024

 Financial Results for quarter and year ended 31.03.2024
See all News

FAQs

The latest market price of Ind-Swift Ltd. on NSE was Rs. 21.15 as of today.

The opening share price of Ind-Swift Ltd. was Rs. 21.30 as of today.

The 52-week high share price of Ind-Swift Ltd. was Rs. 31.20.

The 52 week low share price of Ind-Swift Ltd. was Rs. 11.80.

Ind-Swift Ltd. has a market cap of Rs. 114.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Ind-Swift Ltd. is -0.20. Please refer to the Fundamentals section for further details.

The operating revenue for Ind-Swift Ltd. in the last FY was Rs.  502.25 crore. Please refer to the Financials section for further details.

The Net Profit for Ind-Swift Ltd. in the last FY was Rs. 14.23 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Ind-Swift Ltd. was on 2011-09-21 for Rs. 0.4 per share. According to today’s share price, the dividend yield of Ind-Swift Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by Ind-Swift Ltd. was as of 2005-04-29. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Ind-Swift Ltd..

Close

Let's Open Free Demat Account